CKR-5 Antibodies

Santa Cruz Biotechnology provides a broad selection of CKR-5 monoclonal antibodies for research focused on understanding CKR-5 protein functions. CKR-5 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CKR-5, also known as CCR5, is a chemokine receptor that plays a crucial role in the immune system by mediating the migration of immune cells to sites of inflammation. CCR5 serves as an entry point for HIV infection, as the virus uses this receptor to enter host cells. Understanding CCR5 function has significant implications for developing therapeutic strategies against HIV/AIDS and other inflammatory conditions. CCR5 research continues to reveal new insights about immune cell trafficking and inflammation responses. Ongoing studies of CCR5 are uncovering potential therapeutic applications beyond HIV treatment. Current research explores CCR5's role in various inflammatory and immune-related disorders. Santa Cruz Biotechnology monoclonal antibodies for CCR5 research support scientists in advancing our understanding of immune system regulation and disease mechanisms.